SOPHiA GENETICS SA

NasdaqGS:SOPH 株式レポート

時価総額:US$301.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

SOPHiA GENETICS 将来の成長

Future 基準チェック /26

SOPHiA GENETICS利益と収益がそれぞれ年間22.7%と24%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に-76.3% 23.1%なると予測されています。

主要情報

22.7%

収益成長率

23.1%

EPS成長率

Healthcare Services 収益成長26.8%
収益成長率23.8%
将来の株主資本利益率-76.3%
アナリストカバレッジ

Low

最終更新日22 Jun 2024

今後の成長に関する最新情報

SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Mar 09
SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Mar 09
SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector

Feb 12

Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Dec 27
Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge

Nov 09
Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge

Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?

Aug 08
Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?

Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Dec 15
Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies

Sep 21

SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M

Aug 09

We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely

Jul 01
We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely

SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 18
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price

We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth

Mar 10
We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Nov 24
Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

業績と収益の成長予測

NasdaqGS:SOPH - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2026131-45N/AN/A3
12/31/2025101-55N/AN/A4
12/31/202478-63N/AN/A4
3/31/202464-73-57-48N/A
12/31/202362-79-58-49N/A
9/30/202359-69-58-48N/A
6/30/202354-78-68-58N/A
3/31/202351-82-77-67N/A
12/31/202248-87-80-70N/A
9/30/202245-95-84-75N/A
6/30/202244-93-77-69N/A
3/31/202242-86-73-65N/A
12/31/202140-74-65-58N/A
9/30/202137-63-58-52N/A
6/30/202134-52-51-46N/A
3/31/202130-41-39-35N/A
12/31/202028-39-35-32N/A
12/31/201925-34-35-32N/A

アナリストによる今後の成長予測

収入対貯蓄率: SOPH今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: SOPH今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: SOPH今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: SOPHの収益 ( 24% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: SOPHの収益 ( 24% ) 20%よりも速いペースで成長すると予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: SOPH 3 年以内に赤字になると予測されています。


成長企業の発掘